Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
2112737-71-8 | N-(Aminooxy-peg2)-n-bis(peg3-propargyl) | AA019EB5 | MFCD30828701
2183440-44-8 | Sulfo-Cy5 amine | AA019EFE | MFCD31580126
1251582-36-1 | Ethyl 5-bromo-3-((ethoxycarbonyl)amino)benzofuran-2-carboxylate | AA019EIR | MFCD30185146
2007908-57-6 | N-(4-Fluorobenzyl)-2-oxopyrrolidine-3-carboxamide | AA019ELV | MFCD30472064
111508-26-0 | Ethyl 1-allyl-2-benzylidenehydrazinecarboxylate | AA019EOO | MFCD28991896
1052543-81-3 | 1-([1,2,4]Triazolo[4,3-a]pyridin-3-yl)ethanamine dihydrochloride | AA019ESC | MFCD07685901
1341038-80-9 | 2,3-Dimethyl-2H-indazole-7-carbonitrile | AA019EVO | MFCD30185154
1891162-36-9 | Octahydropyrazino[2,1-C][1,4]Oxazine Hydrochloride | AA019EYV | MFCD28992079
9004-82-4 | Poly(oxy-1,2-ethanediyl), a-sulfo-w-(dodecyloxy)-, sodium salt | AA019FS0 | MFCD01772167
944897-41-0 | 5-(Trifluoromethyl)-4H-1,2,4-triazole-3-carboxylic acid | AA019GAI | MFCD10696474